News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Doyle Katherine C.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Doyle Katherine C. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 7,778 shares
@ $32.86, valued at
$255.6k
Paid exercise price by delivering 3,734 shares
@ $32.86, valued at
$122.7k
Exercised 7,778 restricted stock units
@ $0 |
|
| 05/19/2022 |
4
| Doyle Katherine C. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 6,599 shares
@ $38.57, valued at
$254.5k
Paid exercise price by delivering 3,168 shares
@ $38.57, valued at
$122.2k
Granted 7,778 restricted stock units
@ $0
Exercised 6,599 restricted stock units
@ $0 |
|
| 08/16/2021 |
4
| Doyle Katherine C. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Exercised 5,637 shares
@ $41.28, valued at
$232.7k
Paid exercise price by delivering 2,706 shares
@ $41.28, valued at
$111.7k
Exercised 5,637 restricted stock units
@ $0 |
|
| 05/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2020 |
4
| Doyle Katherine C. (Director) has filed a Form 4 on PERRIGO Co plc|
Txns:
| Granted 5,637 restricted stock units
@ $0 |
|
| 06/11/2019 |
4
| Doyle Katherine C. (Director) has filed a Form 4 on BEMIS CO INC|
Txns:
| Disposed/sold 5,851 shares
@ $0 |
|
| 05/04/2018 |
4
| Doyle Katherine C. (Director) has filed a Form 4 on BEMIS CO INC|
Txns:
| Granted 3,095 shares
@ $0 |
|
| 08/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2014 |
4
| Doyle Katherine C. (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 4,198 shares
@ $39.65, valued at
$166.5k
|
|
| 03/04/2014 |
4
| Doyle Katherine C. (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Paid exercise price by delivering 4,043 shares
@ $39.79, valued at
$160.9k
Sold 1,651 shares
@ $39.004, valued at
$64.4k
Sold 3,888 shares
@ $39.006, valued at
$151.7k
Sold 900 shares
@ $39.011, valued at
$35.1k
Sold 200 shares
@ $39.015, valued at
$7.8k
|
|
| 02/25/2014 |
4
| Doyle Katherine C. (Senior Vice President) has filed a Form 4 on ABBOTT LABORATORIES|
Txns:
| Granted 14,220 shares
@ $0
Granted 87,061 options to buy
@ $39.12, valued at
$3.4M
|
|
| 05/28/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|